Guideline
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
- PMID: 11699843
Item in Clipboard
Guideline
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
MMWR Morb Mortal Wkly Rep.
.
Free article
Erratum in
- MMWR Morb Mortal Wkly Rep 2001 Nov 2;50(43):962
Abstract
Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. This report updates previous findings, provides new information on case investigations in two additional areas, presents the susceptibility patterns of Bacillus anthracis isolates, and provides interim recommendations for managing potential threats and exposures and for treating anthrax.
Similar articles
-
From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.JAMA. 2001 Nov 14;286(18):2226-32. doi: 10.1001/jama.286.18.2226. JAMA. 2001. PMID: 11757528 No abstract available.
-
Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.MMWR Morb Mortal Wkly Rep. 2001 Nov 2;50(43):941-8. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11708591
-
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.MMWR Morb Mortal Wkly Rep. 2001 Oct 19;50(41):889-93. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11686472
-
Recognition and management of anthrax--an update.N Engl J Med. 2001 Nov 29;345(22):1621-6. doi: 10.1056/NEJMra012892. Epub 2001 Nov 6. N Engl J Med. 2001. PMID: 11704686 Review. No abstract available.
-
Zoonosis update. Anthrax.J Am Vet Med Assoc. 2008 Jul 1;233(1):63-72. doi: 10.2460/javma.233.1.63. J Am Vet Med Assoc. 2008. PMID: 18593313 Review. No abstract available.
Cited by
-
New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses.Front Microbiol. 2022 Sep 9;13:1003969. doi: 10.3389/fmicb.2022.1003969. eCollection 2022. Front Microbiol. 2022. PMID: 36160184 Free PMC article.
-
Designing Stable Bacillus anthracis Antigens with a View to Recombinant Anthrax Vaccine Development.Pharmaceutics. 2022 Apr 6;14(4):806. doi: 10.3390/pharmaceutics14040806. Pharmaceutics. 2022. PMID: 35456639 Free PMC article.
-
Systematic Review of Important Bacterial Zoonoses in Africa in the Last Decade in Light of the 'One Health' Concept.Pathogens. 2019 Apr 16;8(2):50. doi: 10.3390/pathogens8020050. Pathogens. 2019. PMID: 30995815 Free PMC article. Review.
-
Sensitive and Specific Recombinase Polymerase Amplification Assays for Fast Screening, Detection, and Identification of Bacillus anthracis in a Field Setting.Appl Environ Microbiol. 2018 May 17;84(11):e00506-18. doi: 10.1128/AEM.00506-18. Print 2018 Jun 1. Appl Environ Microbiol. 2018. PMID: 29602786 Free PMC article.
-
Platelet-activating factor contributes to Bacillus anthracis lethal toxin-associated damage.J Biol Chem. 2014 Mar 7;289(10):7131-7141. doi: 10.1074/jbc.M113.524900. Epub 2014 Jan 29. J Biol Chem. 2014. PMID: 24478317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
